Serum Institute of India received approval to start human trials for Oxford vaccine
On Aug. 1, 2020, the Serum Institute of India (SII) got the approval to start human trials in…
-
-
Mesa Biotech received $15.4 million funding from the NIH for accelerated scale-up and deployment
On Jul. 31, 2020, Mesa Biotech announced it had been awarded a contract up to $15.4 million from…
-
NIH delivered new COVID-19 testing technologies to meet US demand
On Jul. 31, 2020, the National Institutes of Health (NIH) announced that it had invested $248.7 million in…
-
Quidel received NIH contract for $71 million to expand manufacturing capacity for Sofia SARS-CoV-2 antigen test for diagnosis of COVID-19
On Jul. 31, 2020, Quidel announced a preliminary contract with the National Institutes of Health (NIH) to support…
-
Sanofi and GSK announced discussions with EU to supply up to 300 million doses of COVID-19 vaccine
On Jul. 31, 2020, Sanofi and GSK announced advanced discussions, with the European Commission for the supply of…
-
Sanofi and GSK selected for Operation Warp Speed to supply US government with 100 million doses of COVID-19 vaccine
On Jul. 31, 2020, Sanofi and GSK announced a collaborative effort with the U.S. government to accelerate the…
-
Researchers reported fat-based molecules key to Zika virus infection
On Jul. 31, 2020, researchers from the Pacific Northwest National Laboratory (PNNL) and Oregon Health & Science University…
-
OraSure’s OMNIgene-ORAL device included in EUA granted to Clinical Reference Laboratory for self-collected SARS saliva test
On Jul. 31, 2020, OraSure Technologies announced that its OMNIgene-ORAL (OM-505) saliva collection device is included in the…
-
RedHill Biopharma initiated global phase 2/3 study for COVID-19
On Jul. 30, 2020, RedHill Biopharma announced that it has initiated a global Phase 2/3 clinical study evaluating…
-
Biotechnology | COVID-19 | FDA
Precipio announced commercial launch of Covid-19 antibody test
On Jul. 30, 2020, Precipio announced it had entered into an agreement with ADS Biotec, based in Omaha,…
-
Tyson Foods launched nationwide COVID monitoring strategy and expanded health staff
On Jul. 30, 2020, Tyson Foods announced that it had launched a new, industry-leading monitoring program and expanding…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Therapeutics
LabCorp announced work wth public health authorities on no-charge antibody test program to accelerate COVID-19 blood plasma donation
On Jul. 30, 2020, LabCorp launched the LabCorp At Home COVID-19 Test Collection Service, the first seamless digital…
-
BD announced $24 million US Government investment to support scale up of US manufacturing of COVID-19 diagnosic tests
On Jul. 30, 2020, BD (Becton, Dickinson) announced a $24 million investment from the U.S. Department of Defense…
-
Single dose of Johnson & Johnson COVID-19 vaccine candidate demonstrated robust protection in pre-clinical studies
On Jul. 30, 2020, Johnson & Johnson announced that its lead vaccine candidate protected against infection with SARS-CoV-2,…
-
Seqirus began shipping 2020/21 influenza vaccines to U.S. market
On Jul. 30, 2020, Seqirus announced it had begun shipping its portfolio of seasonal influenza vaccines to customers…
-
INOVIO’s COVID-19 DNA vaccine INO-4800 provided protection with memory immune responses In non-human primates challenged with SARS-CoV-2 virus
On Jul. 30, 2020, INOVIO announced that its COVID-19 DNA vaccine INO-4800 targeting SARS-CoV-2 was effective in protecting…
-
NIH researchers discovered new set of channels connecting malaria parasite and blood cells
On Jul. 30, 2020, researchers at the National Institutes of Health and other institutions announced they had discovered…
-
Biotechnology | Diagnostics | Disease | Genomics | NIH | Therapeutics
NIH-funded project created an encyclopedia detailing the inner workings of the human and mouse genomes
On Jul. 29, 2020, the Encyclopedia of DNA Elements (ENCODE) Project is a worldwide effort to understand how…
-
Intravacc and Celonic to develop and produce a novel COVID-19 vaccine
On Jul. 29, 2020, Intravacc and Celonic Group, a biopharmaceutical contract development and manufacturing organization (CDMO), announced that…
-
PharmaCyte Biotech received CE Mark for licensed COVID-19 molecular tests
On Jul. 29, 2020, PharmaCyte Biotech announced that the COVID-19 Molecular tests it has licensed from Hai Kang…
-
Veracyte and MAVIDx announcd agreement for MAVIDx to develop ultra-high volume COVID-19 testing on the nCounter System
On Jul. 29, 2020, Veracyte and MAVIDx announced an agreement for MAVIDx to develop ultra-high throughput genomic testing…
-
Constant Therapeutics announced start of phase 2 trial of peptide drug TXA127 for COVID-19
On Jul. 29, 2020, Constant Therapeutics announced that its peptide drug TXA127, a pharmaceutical formulation of the natural…
-
FDA authorized Quest Diagnostics lab method designed to increase COVID-19 molecular diagnostics capacity
On Jul. 29, 2020, Quest Diagnostics announced that the U.S. Food and Drug Administration (FDA) has granted emergency use…
-
BARDA procured Regeneron’s REGN-EB3 investigational Ebola treatment for national preparedness
On Jul. 29, 2020, Regeneron announced that the Biomedical Advanced Research and Development Authority (BARDA) had entered into…
-
Sanofi and GSK agreed with the UK government to supply up to 60 million doses of COVID-19 vaccine
On Jul. 29, 2020, Sanofi and GSK announced an agreement with the UK government for the supply of…
-
Experimental COVID-19 vaccine protected upper and lower airways in nonhuman primates
On Jul. 28, 2020, scientists at the National Institute of Allergy and Infectious Diseases reported that two doses…
-
Gilead Sciences and Satcher Health Leadership Institute partnered to study racial health inequities associated with COVID-19
On Jul. 28, 2020, Gilead Sciences and the Satcher Health Leadership Institute at Morehouse School of Medicine announced…
-
StartX Med Alliance of Remote and Telehealth companies respond to shift in patient care during COVID-19 crisis
On Jul. 28, 2020, StartX announced the launch of its StartX Med Alliance of Remote and Telehealth (SMART)…
-
Soligenix announced publication of positive pre-clinical results for a novel COVID-19 vaccine
On Jul. 28, 2020, Soligenix announced publication of pre-clinical immunogenicity studies for its CiVax™ program (heat stable COVID-19…
-
Onconova Therapeutics submitted application for rigosertib to participate in federally funded human studies in COVID-19 disease
On Jul. 27, 2020, Onconova Therapeutics announced that it had submitted an application with the National Institute of…
